Kneat.com, Inc. (KSIOF) Research

Kneat.com, Inc. specializes in providing software solutions for streamlining data and document management within highly regulated sectors. The company operates globally, with a presence in the United States, Ireland, and Canada, among other international markets. Its flagship product is the Kneat Gx platform, a configurable, commercial off-the-shelf (COTS) application purpose-built for managing the entire validation lifecycle and associated testing. This powerful tool serves the biotechnology, pharmaceutical, and medical device manufacturing industries. The platform's capabilities encompass a broad spectrum of validation types, such as process, computer system, cleaning, analytical instrument, method, utility and facility, equipment, and cold chain validation. Additionally, it facilitates commissioning, qualification, and electronic logbook management. Kneat.com, Inc. further complements its software offerings with a comprehensive suite of services. These include implementation support like training and installation, system upgrades, expert consulting, and ongoing maintenance. The company also extends its expertise to process mapping, project management, and other strategic services. Headquartered in Limerick, Ireland, Kneat.com, Inc. leads this global effort.

Market snapshot

Symbol
KSIOF
Price
$4.54
Day change
-0.97%
Market cap
$619.1M
P/E ratio
-73.09x
52-week range
2.25-4.95
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Next earnings
in 2 months

Peer companies

  • Clinuvel Pharmaceuticals Limited (CLVLF)
  • Clinuvel Pharmaceuticals Limited (CLVLY)
  • Cogstate Limited (COGZF)
  • Euroapi S.A. (EAPIF)
  • Ion Beam Applications S.A. (IOBCF)
  • Northwest Biotherapeutics, Inc. (NWBO)
  • Oneview Healthcare PLC (ONVVF)
  • Surgical Science Sweden AB (publ) (SUSRF)

Open Kneat.com, Inc. (KSIOF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.